IMC-Chicago »

Crispr Therapeutics shares owned by IMC-Chicago

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by IMC-Chicago from 13F filings

Historical chart of IMC-Chicago investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by IMC-Chicago

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 37k 68.16
2023-12-31 $2.4M 38k 62.60
2023-09-30 $1.4M 31k 45.39
2023-06-30 $879k 16k 56.14
2023-03-31 $630k 14k 45.23
2022-12-31 $850k 21k 40.65
2022-03-31 $1.4M 22k 62.79
2021-12-31 $3.5M 46k 75.78
2021-09-30 $25M 219k 111.93
2021-06-30 $2.1M 13k 161.92
2021-03-31 $2.5M 20k 121.84